Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gin Hwa BiotechROCO:7806 22 PB Ratio is 2.23 as of Jul. 22, 2026, which is 33% below its 10-year median of 3.35. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 1,229 Biotechnology companies, Gin Hwa Biotech ranks better than 59.4% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-22), Gin Hwa Biotech's share price is NT$61.90. Gin Hwa Biotech's Book Value per Share for the quarter that ended in Dec. 2025 was NT$27.79. Hence, Gin Hwa Biotech's PB Ratio of today is 2.23.
Good Sign:
Gin Hwa Biotech Inc stock PB Ratio (=2.23) is close to 2-year low of 2.23.
The historical rank and industry rank for Gin Hwa Biotech's PB Ratio or its related term are showing as below:
ROCO:7806'
s PB Ratio Range Over the Past 10 Years
Min: 2.23 Med: 3.35 Max: 7.31
Current: 2.23
During the past 4 years, Gin Hwa Biotech's highest PB Ratio was 7.31. The lowest was 2.23. And the median was 3.35.
ROCO:7806's PB Ratio is ranked better than 59.4% of 1229
companies
in the Biotechnology industry
Industry Median: 2.82
vs ROCO:7806: 2.23
During the past 12 months, Gin Hwa Biotech's average Book Value Per Share Growth Rate was 42.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 68.80% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Gin Hwa Biotech was 68.80% per year. The lowest was 68.80% per year. And the median was 68.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Gin Hwa Biotech PB Ratio Related Terms
Gin Hwa Biotech PB Ratio Historical Data
* Premium members only.
The historical data trend for Gin Hwa Biotech's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7806 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, Gin Hwa Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gin Hwa Biotech PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's PB Ratio distribution charts can be found below:
* The bar in red indicates where Gin Hwa Biotech's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Gin Hwa Biotech's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Gin Hwa Biotech (ROCO:7806) has a PB Ratio of 2.23 as of Jul. 22, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Gin Hwa Biotech and its competitors. This is 33% below median its historical median of 3.35. Over the past decade, Gin Hwa Biotech's PB Ratio has ranged from 2.23 to 7.31. According to the industry distribution chart, Gin Hwa Biotech ranks #499 out of 1229 companies in the Biotechnology industry, placing it in the top 40.6%.
Is Gin Hwa Biotech's PB Ratio too high?
Gin Hwa Biotech's current PB Ratio of 2.23 is 33% below median its 10-year median of 3.35. Over the past 10 years, this metric has ranged from a low of 2.23 to a high of 7.31. The Biotechnology industry median PB Ratio is 2.82. Gin Hwa Biotech's value of 2.23 is 20.9% below this industry median. Based on the distribution chart, Gin Hwa Biotech ranks #499 out of 1229 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #499 out of 1229 companies for PB Ratio. This puts Gin Hwa Biotech in the upper half of its industry. The industry median PB Ratio is 2.82. Gin Hwa Biotech's value of 2.23 is 20.9% below this benchmark. Historically, Gin Hwa Biotech's own PB Ratio has ranged from 2.23 to 7.31 over the past decade. While the company's 10-year median is 3.35 vs. the industry median of 2.82, Gin Hwa Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.82, based on 1,229 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gin Hwa Biotech's current PB Ratio of 2.23 is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Gin Hwa Biotech and its competitors. For the Biotechnology industry, the median PB Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gin Hwa Biotech's current PB Ratio is 2.23, which is 33% below median its own 10-year median of 3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current PB Ratio of 2.23. The current PB Ratio is 2.23, which is 33% below median its 10-year median of 3.35 and 20.9% below the Biotechnology industry median of 2.82. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current PB Ratio is 2.23 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score
Get the complete analysis for ROCO:7806
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7806 has been successfully added to your 
